Market cap
$15 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
21.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-39.6 %
-
ROCE
-- %
-
Industry P/E
22.53
-
EV/EBITDA
-3
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.4
-
Face value
--
-
Shares outstanding
4,215,112
10 Years Aggregate
CFO
$-42.83 Mln
EBITDA
$-66.33 Mln
Net Profit
$-86.08 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zivo Bioscience (ZIVO)
| -58.5 | 3.2 | 0.2 | -70.4 | -28.2 | -27.7 | -15.2 |
|
BSE Sensex
| -11.7 | -4.8 | 1.1 | -8.2 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Zivo Bioscience (ZIVO)
| -53.5 | 1,650.0 | -92.0 | -12.9 | 1,813.3 | -9.1 | 26.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zivo Bioscience (ZIVO)
|
4.2 | 15.2 | 0.1 | -5.5 | 0.0 | -- | -- | 21.1 |
| 164.4 | 5,470.6 | 1,085.9 | 164.4 | 20.3 | 12.8 | 33.8 | 4.3 | |
| 40.2 | 2,610.7 | 3,084.1 | 166.3 | 8.7 | 10 | 15.4 | 1.5 | |
| 34.7 | 2,257.7 | 3,084.1 | 166.3 | 8.7 | 10 | 13.4 | 1.3 | |
| 65.1 | 10,473.4 | 6,555.5 | 597.9 | 14.7 | 11.8 | 18.1 | 2.0 | |
| 63.7 | 3,375.6 | 1,177.3 | 203.5 | 13.4 | 16.6 | 18.1 | 2.7 | |
| 30.2 | 7,257.6 | 18,436.0 | 545.6 | 5.2 | 14.7 | 13.3 | 2.0 | |
| 80.2 | 3,638.5 | 8,412.5 | 293.0 | 9.7 | 8.9 | 14.8 | 1.2 | |
| 4,296.0 | 4,114.7 | 10,272.0 | 634.0 | 4.2 | 11.8 | 6.5 | 0.8 | |
| 38.9 | 2,883.3 | 734.7 | 95.5 | 17.7 | 10.1 | 30 | 3.0 |
Shareholding Pattern
View DetailsAbout Zivo Bioscience (ZIVO)
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company... operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan. Read more
-
President, CEO & Chairman of the Board
Mr. John B. Payne
-
President, CEO & Chairman of the Board
Mr. John B. Payne
-
Headquarters
Troy, MI
-
Website
FAQs for Zivo Bioscience (ZIVO)
What is the current share price of Zivo Bioscience Inc (ZIVO) Today?
The share price of Zivo Bioscience Inc (ZIVO) is $4.15 (NASDAQ) as of 11-Sep-2026 13:56 EDT. Zivo Bioscience Inc (ZIVO) has given a return of -28.22% in the last 3 years.
What is the current PB & PE ratio of Zivo Bioscience Inc (ZIVO)?
Since, TTM earnings of Zivo Bioscience Inc (ZIVO) is negative, P/E ratio is not available.
The P/B ratio of Zivo Bioscience Inc (ZIVO) is 21.13 times as on 04-Sep-2026, a 1087 premium to its peers’ median range of 1.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-3.93 |
-10.36 |
2024 |
-5.48 |
-142.40 |
2023 |
-0.27 |
-0.94 |
2022 |
-0.45 |
-369.49 |
2021 |
-2.88 |
4.47 |
What is the 52 Week High and Low of Zivo Bioscience Inc (ZIVO)?
The 52-week high and low of Zivo Bioscience Inc (ZIVO) are Rs 18.24 and Rs 1.17 as of 12-Sep-2026.
What is the market cap of Zivo Bioscience Inc (ZIVO)?
Zivo Bioscience Inc (ZIVO) has a market capitalisation of $ 15 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Zivo Bioscience Inc (ZIVO)?
Before investing in Zivo Bioscience Inc (ZIVO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.